$32b
Ireland’s Shire bags Illinois-based Baxalta. After a six-month pursuit, the pharma giants will merge to create the world’s leading maker of drugs for rare diseases, such as hemophilia.
Ireland’s Shire bags Illinois-based Baxalta. After a six-month pursuit, the pharma giants will merge to create the world’s leading maker of drugs for rare diseases, such as hemophilia.